{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:53:17Z","timestamp":1789152797351,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.clnesp.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:51:57Z","timestamp":1754452317000},"page":"590-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Outcomes of glepaglutide on intestinal absorption and parenteral support in patients with short bowel syndrome"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-4575","authenticated-orcid":false,"given":"Ismail","family":"Pinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor Sch\u00fctt Svane","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Soldbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Krogh","family":"Hvistendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berner-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle Bekker","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clnesp.2025.08.006_bib1","first-page":"201","article-title":"Nutritional and medical approaches to intestinal failure","volume":"26","author":"Salazar","year":"2023","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jviscsurg.2017.12.012","article-title":"Medical and surgical management of short bowel syndrome","volume":"155","author":"Billiauws","year":"2018","journal-title":"J Vis Surg"},{"key":"10.1016\/j.clnesp.2025.08.006_bib3","unstructured":"Dosing & administration for GATTEX\u00ae (teduglutide). Available from: https:\/\/www.gattex.com\/dosing-and-administration\/."},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jpen.2223","article-title":"Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo-controlled, randomized phase 2 trial","volume":"46","author":"Eliasson","year":"2022","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.gastro.2024.11.023","article-title":"Glepaglutide, a long-acting glucagon-like peptide-2 analogue, reduces parenteral support in patients with short bowel syndrome: A phase 3 randomized controlled trial","volume":"168","author":"Jeppesen","year":"2025","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00365520410004424","article-title":"Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1","volume":"39","author":"Nagell","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.clnesp.2025.08.006_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of glepaglutide, a long-acting glucagon-like peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.clnesp.2025.08.006_bib10","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jcem.84.7.5840","article-title":"Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2","volume":"84","author":"W\u00f8jdemann","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clnesp.2025.08.006_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1177\/0148607115597644","article-title":"Acute effects of a glucagon-like peptide 2 analogue, teduglutide, on gastrointestinal motor function and permeability in adult patients with short bowel syndrome on home parenteral nutrition","volume":"40","author":"Iturrino","year":"2016","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"15","key":"10.1016\/j.clnesp.2025.08.006_bib12","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.clnesp.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jpen.2389","article-title":"Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: findings from a randomized phase 2 trial","volume":"47","author":"Naimi","year":"2023","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.08.006_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gut.47.1.112","article-title":"Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse","volume":"47","author":"Benjamin","year":"2000","journal-title":"Gut"},{"issue":"1\u20133","key":"10.1016\/j.clnesp.2025.08.006_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.regpep.2011.03.003","article-title":"The effect of glucagon-like peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients","volume":"168","author":"Bremholm","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/j.clnesp.2025.08.006_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2012.10.002","article-title":"Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients","volume":"180","author":"H\u00f8yerup","year":"2013","journal-title":"Regul Pept"},{"issue":"1 Suppl","key":"10.1016\/j.clnesp.2025.08.006_bib17","first-page":"8S","article-title":"Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure","volume":"38","author":"Jeppesen","year":"2014","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2025.08.006_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/gut.2003.030601","article-title":"Net digestive absorption and adaptive hyperphagia in adult short bowel patients","volume":"53","author":"Crenn","year":"2004","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.clnesp.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/01.mcg.0000212678.14172.7a","article-title":"Dietary and medical management of short bowel syndrome in adult patients","volume":"40","author":"Matarese","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"1 Suppl","key":"10.1016\/j.clnesp.2025.08.006_bib20","first-page":"23S","article-title":"Intestinal adaptation following resection","volume":"38","author":"Tappenden","year":"2014","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"5972","key":"10.1016\/j.clnesp.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.2.5972.667","article-title":"Loperamide and ileostomy output \u2014 placebo-controlled double-blind crossover study","volume":"2","author":"Tytgat","year":"1975","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.clnesp.2025.08.006_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bcpt.12830","article-title":"The acute effect of loperamide on ileostomy output: a randomized, double-blinded, placebo-controlled, crossover study","volume":"121","author":"Kristensen","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.clnesp.2025.08.006_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/gut.19.5.377","article-title":"Effect of codeine phosphate, Lomotil, and Isogel on ileostomy function","volume":"19","author":"Newton","year":"1978","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clnesp.2025.08.006_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.43.6.763","article-title":"Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection","volume":"43","author":"Jeppesen","year":"1998","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clnesp.2025.08.006_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.08.006_bib26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jpen.2362","article-title":"Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: an open-label phase 1 and 2 metabolic balance trial","volume":"46","author":"Eliasson","year":"2022","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2025.08.006_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.clnesp.2025.08.006_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2468-1253(19)30077-9","article-title":"Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial","volume":"4","author":"Naimi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2025.08.006_bib29","first-page":"1","article-title":"Short bowel patients treated for two years with glucagon-like peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function","volume":"2009","author":"Jeppesen","year":"2009","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnesp.2025.08.006_bib30","article-title":"Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life","volume":"2009","author":"Jeppesen","year":"2009","journal-title":"Gastroenterol Res Pract"},{"issue":"7","key":"10.1016\/j.clnesp.2025.08.006_bib31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clnesp.2025.08.006_bib32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2025.08.006_bib33","first-page":"1","article-title":"Glepaglutide, a long-acting glucagon-like peptide-2 analog, reduces parenteral support in patients with short bowel syndrome: a phase 3, randomized, controlled trial","author":"Jeppesen","year":"2024","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.clnesp.2025.08.006_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40261-022-01210-1","article-title":"Pharmacokinetics of glepaglutide, a long-acting glucagon-like peptide-2 analogue: a study in healthy subjects","volume":"42","author":"Agersnap","year":"2022","journal-title":"Clin Drug Invest"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2017.11.023","article-title":"Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure","volume":"154","author":"Jeppesen","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clnesp.2025.08.006_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0016-5085(03)70064-X","article-title":"AGA technical review on short bowel syndrome and intestinal transplantation","volume":"124","author":"Buchman","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clnesp.2025.08.006_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpg.2016.02.011","article-title":"Definitions of intestinal failure and the short bowel syndrome","volume":"30","author":"Pironi","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.08.006_bib38","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"issue":"12","key":"10.1016\/j.clnesp.2025.08.006_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clnu.2024.10.011","article-title":"Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon\u2013in\u2013continuity: A multicenter, open-label, metabolic balance study","volume":"43","author":"Verbiest","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.08.006_bib40","article-title":"Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function","volume":"2009","author":"Jeppesen","year":"2009","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"10.1016\/j.clnesp.2025.08.006_bib41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/gut.2003.035212","article-title":"Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice","volume":"53","author":"Thulesen","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2025.08.006_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.peptides.2017.03.008","article-title":"Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway","volume":"91","author":"Shawe-Taylor","year":"2017","journal-title":"Peptides"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772502892X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772502892X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:53:46Z","timestamp":1779234826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772502892X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S240545772502892X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.08.006","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of glepaglutide on intestinal absorption and parenteral support in patients with short bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}